Posted in

News And Events

Three-Year Follow-Up of a Prospective, Double Blinded Multi-Center RCT Evaluating DBS with a Multiple Source, Constant-Current Rechargeable System for Treatment of Parkinson’s Disease (INTREPID)

Congratulations Drs. Okun and Foote on the publication of “Three-Year Follow-Up of a Prospective, Double Blinded Multi-Center RCT Evaluating DBS with a Multiple Source, Constant-Current Rechargeable System for Treatment of Parkinson’s Disease (INTREPID).”  This article was published in the November 16, 2020 issue of NeuroSurgery.   Abstract INTRODUCTION…

Eye Exam Could Lead to Early Parkinson’s Disease Diagnosis

For the new study, Diaz collaborated with graduate student Jianqiao Tian and University of Florida neurologist Adolfo Ramirez-Zamora, M.D., under the direction of Ruogu Fang, Ph.D., director of the J. Crayton Pruitt Department of Biomedical Engineering’s Smart Medical Informatics Learning and Evaluation Lab (SMILE). The researchers deployed a type of…

New study tests effectiveness of high-intensity exercise in slowing Parkinson’s symptoms

The University of Florida is collaborating on a new Phase 3 multisite clinical trial that will test the effectiveness of high-intensity and moderate-intensity treadmill exercise in slowing the progression of Parkinson’s disease symptoms. The new research study, SPARX3, led by Northwestern University, will enroll 370 participants who were recently diagnosed…

A New MRI Measure to Early Differentiate Progressive Supranuclear Palsy From De Novo Parkinson’s Disease in Clinical Practice: An International Study

Congratulations Dr. Nikolaus McFarland on the publication of “A New MRI Measure to Early Differentiate Progressive Supranuclear Palsy From De Novo Parkinson’s Disease in Clinical Practice: An International Study.”  This paper was published in the November 2020 issue of Movement Disorders. ABSTRACT Background Enlargement of the third ventricle has…

Reforming the process for DBS and neurological device approval in rare diseases

For some patients with common neurological diseases like Parkinson’s disease, treatment using neurotechnological devices such as deep brain stimulation has been successful in improving their symptoms. But in a new JAMA Neurology Viewpoint article, Michael S. Okun, M.D., UF’s chair of neurology, and James Giordano, Ph.D., of Georgetown University, argue…

The SYNODOS Dystonia Summit 2020

Thank you to all who are planning to attend this year’s Tyler’s Hope Think Tank !  Please see the attached schedule. We have planned for three sessions. Each talk for the Tyler’s Hope Think Tank is 20 minutes long; however, at the end of each session, we will have about…